Abstract
A 63-year-old woman with amyotrophic lateral sclerosis (ALS) was scheduled for open reduction and internal fixation of the right tibia. Total intravenous anesthesia using propofol and remifentanil without muscle relaxant was selected as the anesthetic method, in order to avoid the possible occurrence of ventilatory depression due to abnormal responses to muscle relaxants and exacerbation of the motor neuron disease. After standard and neuromuscular monitoring devices were applied, anesthesia was induced and maintained with target controlled infusion of propofol and remifentanil in the range of 2.5–5.0 μg·ml−1 and 2.5–5.0 ng·ml−1, respectively. To avoid delayed neuromuscular recovery, we did not use any muscle relaxant at all. Intubation was successful and there were no remarkable events during anesthesia, except for three brief hypotensive events; there was no exacerbation of ALS itself during or after the anesthesia. She was discharged on postoperative day 3, without any discomfort.
Similar content being viewed by others
References
Vandem LD, Dripps RD. Exacerbation of preexisting neurologic disease after spinal anesthesia. N Engl J Med. 1956;255:843–849.
Nicolas F, Sollet JP, Mathe JF. Aggravation following anaesthesia in a case of unknown lateral amyotrophic sclerosis (author’s translation). Anesth Analg. 1979;36:235–238.
Naguib M, Lien CA. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, editor. Anesthesia. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 515–516.
Kim TK, Kwon JE, Kim YL. General anesthesia in a patient with amyotrophic lateral sclerosis. Korean J Anesthesiol. 2007;51:S18–S19.
Diefenbach C, Buzello W. Muscle relaxation in patients with neuromuscular diseases. Anaesthesist. 1994;43:283–288.
Mashio H, Ito Y, Yanagita Y, Fujisawa E, Hada K, Goda Y, Kawahigashi H. Anesthetic management of a patient with amyotrophic lateral sclerosis (in Japanese with English abstract). Masui (Jpn J Anesthesiol). 2000;49:191–194.
Rosenbaum KJ, Neigh JL, Strobel GE. Sensitivity to nondepolarizing muscle relaxants in amyotrophic lateral sclerosis: report of two cases. Anesthesiology. 1971;35:638–641.
Morgan GE, Mikhail MS, Murray MJ. Nonvolatile anesthetic agents. In: Morgan GE, editor. Clinical anesthesiology. 4th ed. New York: Lange Medical Books/McGraw-Hill; 2006. p. 200–201.
Morgan GE, Mikhail MS, Murray MJ. Nonvolatile anesthetic agents. In: Morgan GE, editor. Clinical anesthesiology. 4th ed. New York: Lange Medical Books/McGraw-Hill; 2006. p. 194.
Stucke AG, Stuth EA. Use of rapacuronium in a child with spinal muscular atrophy. Paediatr Anaesth. 2001;11:725–728.
Ali HH, Savarese JJ. Monitoring of neuromuscular function. Anesthesiology 1976;45:216–249.
Kochi T, Oka T, Mizuguchi T. Epidural anesthesia for patients with amyotrophic lateral sclerosis. Anesth Analg. 1989;68:410–412.
Hara K, Sakura S, Saito Y, Maeda M, Kosaka Y. Epidural anesthesia and pulmonary function in a patient with amyotrophic lateral sclerosis. Anesth Analg. 1996;83:878–879.
Author information
Authors and Affiliations
About this article
Cite this article
Lee, D., Lee, K.C., Kim, J.Y. et al. Total intravenous anesthesia without muscle relaxant in a patient with amyotrophic lateral sclerosis. J Anesth 22, 443–445 (2008). https://doi.org/10.1007/s00540-008-0655-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-008-0655-x